CXCL10 and interstitial lung disease: The study conducted by Gono et al. revealed that PM/DM patients with ILD exhibited elevated serum levels of IL-4, IL-6, IL-8, IL-10, TNF-α, and CXCL10 prior to treatment in comparison with PM/DM patients without ILD [37].